Mammalian BET proteins, most notably Brd4, have raised broad biomedical interest as well, because they can support several types of cancer, including NUT midline carcinoma, multiple myeloma and acute leukemia [44–47]. This evidence concerns the gene BRD4 and plasma cell myeloma.